Statistics for BO-264: Highly potent TACC3 inhibitor as a novel anticancer drug candidate
Total visits
| views | |
|---|---|
| BO-264: Highly potent TACC3 inhibitor as a novel anticancer drug candidate | 30 |
Total visits per month
| views | |
|---|---|
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 2 |
| February 2025 | 1 |
| March 2025 | 1 |
| April 2025 | 3 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Ozge Akbulut_MBG_MFBE_January 2021.pdf | 96 |
Top country views
| views | |
|---|---|
| Turkey | 12 |
| China | 5 |
| United States | 5 |
| United Kingdom | 2 |
| India | 2 |
| Poland | 2 |
| Hong Kong SAR China | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Istanbul | 7 |
| Beijing | 3 |
| Hangzhou | 2 |
| Kastamonu | 2 |
| Waipahu | 2 |
| Warsaw | 2 |
| Ankara | 1 |
| Bergama | 1 |
| Blackheath | 1 |
| Brooklyn | 1 |
| Cankaya | 1 |
| Charleston | 1 |
| London | 1 |
| Lviv | 1 |
| Panjim | 1 |
| Pune | 1 |
| San Antonio | 1 |